This segment focuses on the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. Siegfried utilizes advanced chemical synthesis, fermentation, and extraction technologies to produce APIs for a wide range of therapeutic areas, including anesthetics, pain management, and central nervous system disorders. The company's R&D activities include process optimization, analytical method development, and scale-up to commercial manufacturing. Siegfried's market positioning is strong due to its expertise in complex chemistry and its ability to provide high-quality APIs to pharmaceutical companies worldwide. Future opportunities include expanding its API portfolio and entering new therapeutic areas. Regulatory compliance and adherence to stringent quality standards are critical aspects of this segment, ensuring patient safety and product efficacy. Siegfried collaborates with various pharmaceutical companies to develop and manufacture APIs.

This segment encompasses the development and manufacturing of finished dosage forms, including solid oral dosage forms, sterile and aseptic filling liquid dosage forms. Siegfried offers a comprehensive range of services, including formulation development, analytical testing, and commercial manufacturing. The company utilizes advanced technologies such as spray drying, granulation, and aseptic filling to produce high-quality drug products. Therapeutic areas include a wide range of applications. Siegfried's market position is enhanced by its ability to provide integrated CDMO services, from API to finished product. Future growth opportunities include expanding its sterile manufacturing capabilities and developing new dosage forms. Regulatory compliance, including FDA and EMA approvals, is a key focus. Siegfried collaborates with pharmaceutical companies to bring innovative drug products to market.

Siegfried's CDMO segment provides comprehensive services to pharmaceutical and biotechnology companies, including process and chemical development, analytical development, pilot manufacturing, scale-up, and commercial manufacturing. The company leverages its expertise in various technologies, including chemical synthesis, formulation development, and aseptic manufacturing, to support the development and production of drug substances and drug products. This segment serves a broad range of therapeutic areas, from oncology to central nervous system disorders. Siegfried's market position is strengthened by its global network of manufacturing sites and its ability to provide integrated solutions. Future opportunities include expanding its service offerings and entering new markets. Regulatory compliance and adherence to quality standards are critical for success. Siegfried actively collaborates with pharmaceutical companies to accelerate drug development and commercialization.